Wilfried J. Graveland

Author

Also Known As

Alexander M. M. Eggermont, W GRAVELAND, W J Graveland, W. Graveland, W. J. Graveland, W.J. Graveland, Wilfried Graveland, Wilfried J Graveland, Wilfried J. Graveland

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus MC Cancer Institute Rotterdam University of Applied Sciences Erasmus University Rotterdam Sidney Kimmel Comprehensive Cancer Center

About

Wilfried J. Graveland is an author at Erasmus MC specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	573
2	Health Sciences	4	4	373
3	Neurology	1	1	115
4	Orthopaedics	1	1	39
5	Pathology	1	1	115

Wilfried J. Graveland

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients Felix E. de Jongh, Ruben N. van Veen, S J Veltman, British Journal of Cancer	2003	265
Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features Martin J. van den Bent, Leendert H. J. Looijenga, Karin P.S. Langenberg, Cancer	2003	197
Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor‐α and melphalan for limb‐threatening soft tissue sarcoma Dirk J. Grünhagen, Johannes H. W. de Wilt, Wilfried J. Graveland, Cancer	2006	137
Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients Sharyn D. Baker, Ron H. N. van Schaik, Laurent P. Rivory, Clinical Cancer Research	2004	126
One Hundred Consecutive Isolated Limb Perfusions With TNF-α and Melphalan in Melanoma Patients With Multiple In-Transit Metastases Dirk J. Grünhagen, Flávia Brunstein, Wilfried J. Graveland, Annals of Surgery	2004	125
Prediction of Irinotecan Pharmacokinetics by Use of Cytochrome P450 3A4 Phenotyping Probes Ron H.J. Mathijssen, Floris A. de Jong, Ron H. N. van Schaik, JNCI Journal of the National Cancer Institute	2004	124
Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans John R. van Sörnsen de Koste, Frank J. Lagerwaard, Margriet R.J Nijssen-Visser, International Journal of Radiation OncologyBiologyPhysics Computed TomographyLung TumorsMedical ImagingMedicineMultiple Pulmonary Nodule	2003	122
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment Mathilde C.M. Kouwenhoven, Johan M. Kros, Pim J. French, European Journal of Cancer Neuro-oncologyRadiation OncologyMedicineFirst Line TemozolomidePathology	2006	115
Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly Albert J. ten Tije, Jaap Verweij, Michael A. Carducci, Journal of Clinical Oncology	2005	112
High positive sentinel node identification rate by EORTC melanoma group protocol Alexander C. J. van Akkooi, Johannes H. W. de Wilt, Cornelis Verhoef, European Journal of Cancer Radiation OncologyMelanomaRadiologyHealth Sciences	2006	102

Page 1